HUL fourth-quarter volume growth down 7%, profit falls 1%, India sales slide 9% — as COVID-19 strikes India’s largest consumer firm
Hindustan Unilever’s fourth-quarter earnings showed a 1% fall in profit after tax, a 9% fall in domestic sales, and a 7% fall in volume growth.
- The share price of India’s largest fast-moving consumer goods major ended 1.2% lower on a day that the Sensex rallied over a 1,000 points.
- With the supply chain impacted due to the coronavirus lockdown across the country, overall revenue has been affected on expected lines
AdvertisementHindustan Unilever’s fourth-quarter earnings showed a 1% fall in profit after tax, a 9% fall in domestic sales, and a 7% fall in volume growth. The share price of India’s largest fast-moving consumer goods major ended 1.2% lower on a day that the Sensex rallied over a 1,000 points.
COVID-19 lockdown hits
With the supply chain impacted due to the coronavirus lockdown across the country, overall revenue has been affected on expected lines. “Demand patterns are changing, and we are likely to see an upswing in categories like health, hygiene and nutrition. In the near term, we are also likely to see some adverse impact on discretionary categories and out of home channel,” the company statement said.
Earlier on April 23, Unilever withdrew its full year forecast and had said that it cannot assess the impact of coronavirus on its business.
Many of HUL products come under essentials along with LifeBuoy sanitizers and hand wash in its brands, however that wasn’t expected to help the company. “High stocking up will not compensate for the soft demand for a long period. HUL has ramped up supply for soaps and sanitizers for a while now since the outbreak in China. People are, however, hoarding these products to a very large extent and hence it is difficult to meet demand,” an Edelweiss estimate had said earlier.
The biggest food company in India
With its merger with Glaxosmithkline Consumer Healthcare (GSK), Hindustan Unilever became the biggest food company in India. According to reports, GSK is also planning to sell 5.7% stake in HUL worth $3.7 billion. Through the merger HUL acquired Horlicks from GSK for ₹30.5 billion.
However, after the deal was sealed, GSK has decided to dump the $3.9 billion worth HUL shares that it received as part of the deal. The expected flooding of shares in the market from GSK also took the HUL stock down in trade three days in a row, ahead of today’s earnings report.
India's blue-chip indices see a dizzying rally this week thanks to a series of good news— these are the top gainers and what pumped them up
Here is a list of top 25 stocks that qualify for ‘Ten Baggers’, according to Ambit
Popular on BI
- Budget to aid flagging affordable home segment, boosts demand with infra push
- BYJU's slashes over 1,000 jobs, mostly from its engineering teams
- Budget 2023-24: Positive for infra and credit growth
- Budget 2023-24: Continued focus on infra to enable growth, create jobs & enhance quality of life
- Budget 2023 proposes 20% TCS on foreign expenses under LRS